chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chronic urticaria, intense itching of the skin on scalp, ears, face, back, arms and legs.  Taking daily Claritin helps, but Claritin has side effects of dryness of skin. This is still happening now, January 1st, 2013. Last time I had a flu shot is lasted 1.5 years. I skipped a flu shot one year in between due to same reaction last time. My employer requires us to have the flu shot, with only anaphylaxis as an accepted excuse.
8 by 4 cm of erythema on right thigh with induration contiguous with MMR-Varicella immunization.  Symptoms reported resolved 4 days after immunization given.
Received Covid-19 vaccine on 02/01/21 for his first shot then received other COVID-19 vaccine on 02/22/21 for his second shot
30 minutes of rapid heart rate and fluttering; shortness of breath; supraventricular tachycardia; Dizzy; diaphoretic; Palpitations; Fatigue; nauseous; This regulatory authority case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of CARDIAC FLUTTER (30 minutes of rapid heart rate and fluttering) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Dec-2020, the patient experienced CARDIAC FLUTTER (30 minutes of rapid heart rate and fluttering) (seriousness criterion medically significant), DYSPNOEA (shortness of breath), SUPRAVENTRICULAR TACHYCARDIA (supraventricular tachycardia), DIZZINESS (Dizzy), HYPERHIDROSIS (diaphoretic), PALPITATIONS (Palpitations), FATIGUE (Fatigue) and NAUSEA (nauseous). On 21-Dec-2020, CARDIAC FLUTTER (30 minutes of rapid heart rate and fluttering) had resolved. At the time of the report, DYSPNOEA (shortness of breath), SUPRAVENTRICULAR TACHYCARDIA (supraventricular tachycardia), DIZZINESS (Dizzy), HYPERHIDROSIS (diaphoretic), PALPITATIONS (Palpitations), FATIGUE (Fatigue) and NAUSEA (nauseous) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Dec-2020, Electrocardiogram: abnormal (abnormal) supraventricular tachycardia. On 21-Dec-2020, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were provided. About 3 hours after receiving vaccine, patient had 30 minutes of rapid heart rate, and fluttering. She laid down, went to sleep, and it resolved. She didn't seek emergency care. Did not have chest pain or shortness of breath.  Continued to have palpitations occasionally, fatigue, tachycardia. She presented to primary care professional on 07 Jan 2021 for symptoms and was transferred to for additional cardiac workup and treatment after capturing supraventricular tachycardia (SVT) on electrocardiogram (EKG). Also diaphoretic, dizzy, nauseous, shortness of breath with palpitations. She was given IV metoprolol in ED with conversion to normal sinus rhythm (NSR). They suspect that the vaccine may have been her trigger. She was able to discharge without escalation of care.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Pt. states that after receiving the 2nd dose of Shingrix 12/07/2021, started experiencing symptoms that night of fever, rash in and around the chest/abdomen area, and swelling at the injection. No noted Primary visit/communications. Symptoms have subsided, rash is fading.
Information has been received from a nurse concerning a 14 year old female who on 26-JUN-2007 was vaccinated with varicella virus vaccine live (Oka/Merck) (lot no. 657449/0597U). On 28-JUN-2007, the patient developed a 3 inch diameter of redness at injection site to her L arm. This is one of several reports received from the same source. No further information is available.
9/13/02 pt received DTaP #2, IPV #2, Hib #2, hep B #2, Prevnar #1. 9/14/02 pt had seizure, lasted 2 minutes. No fever. Seen in ER and given antibiotic shot after blood/urine labs. Told may have been febrile seizure and may have been pertussis rx. Follow up: no site reaction that was remarkable.  May split vaccines and give seperate parts of some.
Pt. state he developed a fever, rash, swelling of the glands in his neck, joint pain and stiffness, fatigue, and an overall sense of illness.  This lasted for 4-5 days.
Redness and swelling around site of immunization on client right thigh.  The swelling was stated to be the size of an orange.  Area was also painful to the touch and red with white area around injection site.
7 YO patient was administered Kinrix; Was supposed to receive IPOL and "something else"; Already received 5 of DTaP and 4 of IPV; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 7-year-old male patient who received DTPa-IPV (Kinrix) (batch number 24T2N, expiry date 07-MAY-2023) for prophylaxis.   Previously administered products included DTaP (received 5 doses of DTaP) and IPV (4 years child received 4 doses of IPV).   On 16-FEB-2023, the patient received Kinrix. On 16-FEB-2023, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: 7 YO patient was administered Kinrix), wrong vaccine administered (Verbatim: Was supposed to receive IPOL and "something else") and inappropriate schedule of vaccine administered (Verbatim: Already received 5 of DTaP and 4 of IPV). The outcome of the inappropriate age at vaccine administration, wrong vaccine administered and inappropriate schedule of vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 16-Mar-2023 The nurse reported that the 7 year old patient was administered a dose of Kinrix.  The nurse believes the patient was supposed to have received IPOL and something else but she was not sure.  The nurse reported that prior to the Kinrix dose, the patient had already received 5 doses of DTaP and 4 doses of IPV, however the fourth dose of IPV was given before the child was 4 years of age.  The reporter consented to follow up.  The Vaccine Administration Facility is the same as Primary Reporter. The 7 year old patient was administered a dose of Kinrix, which led to age at vaccine administration, wrong vaccine administered, inappropriate schedule of vaccine administered.
About 4 hrs p/recvd DTP/OPV/HIB pt had shallow breathing, pallor, periorbital caynosis, & difficulty arousing; event lasted about 20 minutes; pt appeared healthy in my office 1 hr later; no fever was noted then;
Soreness and stiffness at injection within 6 hours.  Chills, body ache, headache, malaise 30 hours after injection. Treated with sleep , asa 640mg
patient received a dose of expired Pediarix.; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 6-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number MG92G, expiry date 3rd May 2021) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 28th June 2021, the patient received Pediarix (intramuscular) and Pediarix Pre-Filled Syringe Device. On 28th June 2021, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter stated that, the patient received a dose of expired Pediarix. The reporter consented to follow up.
09/25/09 10:22AM returned client's call. She received a Flu vacc. 09/23/09, Wed., and on 09/24/09 she has pain,redness, and swelling LDT, injection site, with bumps and itching. She called her MD and was instructed to take OTC Benadryl. The pain,redness, and itching are better today.
no aditional AE; freezer underwent an excursion and they did not realize the excursion until later/temperature excursion for VARIVAX and PROQUAD/ VARIVAX and PROQUAD may have been administered to multiple patients; This spontaneous report has been received from a nurse, concerning a 11-month-old male patient. The patient's pertinent medical history, concurrent conditions, previous drug reactions or allergies, and concomitant medications were not provided.  On 15-MAY-2023, the reporter's freezer underwent a temperature excursion; in which varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) were stored. On that same day, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) lot # W035466 and W017567 with following expiration dates 06-MAY-2024 and 29-NOV-2023, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided).  Other suspect therapies included varicella virus vaccine live (oka/merck) (VARIVAX) lot # U039723 and W031812   with following expirations dates 15-DEC-2023 and 05-OCT-2024, 0.5 milliliter for prophylaxis (dose number and route of administration were not provided) (product storage error and no adverse event).; Sender's Comments:  US-009507513-2306USA004086: US-009507513-2306USA004087: US-009507513-2306USA004090: US-009507513-2306USA004089: US-009507513-2306USA004085: US-009507513-2306USA004084: US-009507513-2306USA004088: US-009507513-2306USA004082: US-009507513-2305USA007959:
Within 24-hours of receiving these vaccinations, my daughter had her first grand-mal seizure and absence seizure. Her medical staff tried to say it was a febrile seizure; however, she has had the flu, with a fever, documented prior to this, and she never had any seizures then. Over the last 2+ years, we have tried every seizure medication with no seizure control what-so-ever. My daughter has over 1,230 reported seizures a day, according to her most recent EEG three weeks ago. It wasn't until recently, a Dr. suggested a water pill to help relieve possibly water off her brain, which can be caused by the MMR vaccination.
Minor Outbreak of hives approximately 1 hour after the shot.  Second outbreak of hives covering entire body on April 5, 2021
Starts with blurred vision, followed by headaches.  Treatment; 600mg Advil   Headaches last for about 24hrs
fatigue, weakness, headache since Friday, October 29. Symptoms seem to lessen each day but are continuing.
Appt at 11AM today HPV #3 given Mom called at 1:30 to report child c/o itchy on chin, neck, chest, armpit and stomach. Denied any difficulty breathing or swallowing or dizziness.
IR LEVEL JUMPED FROM 2.2 TO 4.4 AFTER VACCINE (on blood thinner).
Pt received  pneumococcal vaccine in L arm on Wednesday 3/22 at 3pm, started feeling bad and lightheaded within an hour, pt continued to feel bad throughout the night, then developed a fever on Thursday AM and her L arm was swollen with shooting pain. Thursday night she was bedridden with the chills, shakes, N/V, and severe headache. The shooting pain by then  spread to the whole left side accompanied with chest pain.  Pt called the appointment line on Friday early morning and was told to call 911.  Pt was then taken to the ER by a friend within 30 min.  Her BP was fond to be low and WBC was very elevated.  Pt was diagnosed with cellulitis and sepsis.  Pt is returned home on 3/27.  At the time of phone call on 3/28, pt still has shooting pain in the L arm and neck. The injection site is still very tender to touch.  Pt was discharged with antibiotics and pain meds. she continues to rotate percocet w/ ibuprofen every 6 hrs as instructed.
nausea; vomiting; chills; headache; This is a spontaneous report from a non-contactable nurse (patient). A 55-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EL1283), via an unspecified route of administration on 07Jan2021 at 10:30 AM on the left arm at a single dose for COVID-19 immunization.  Medical history included allergies to sulfa. The patient's concomitant medications were not reported. The patient previously received the first dose of (Pfizer-BioNTech COVID-19 mRNA vaccine, lot no: EJ1685) on 21Dec2020 at 10:00 AM on the left arm for COVID-19 immunization. The vaccine was administered in the hospital. The patient was not administered any other vaccine in four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The patient experienced nausea, vomiting, chills and headache on 07Jan2021 at 11:45 PM. The patient did not receive treatment for the events. The outcome of the events was recovering. The events were reported to be non-serious.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a medical assistant refers to a 63 years old patient. The patient was subcutaneously vaccinated with 0.5 ml VARIVAX (Merck) (Lot# unspecified) on 21-SEP-2012 instead of ZOSTAVAX. The patient was not experiencing any known symptoms. No treatment information was reported. The outcome was unknown. Additional information has been requested.
A little bit of soreness in arm injection was administered; This is a spontaneous report from a contactable consumer. A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration in eft arm on 14Jan2021 09:05 at a single dose for vaccination. There were no relevant medical history and concomitant medications. The patient previously received flu shot on Sep2020. The patient experienced a little soreness in arm injection was administered on 14Jan2021 and recovered completely from this event by the evening of 14Jan2021. She was feeling good. Described the event as very minor, minimal similar to what one might get with a flu or tetanus shot.  Information on Lot/Batch has been requested.
I experienced severe fatigue and headache that lasted 8 days. The vaccine also triggered a severe depressive state that I had not experienced before. This also lasted 8 days.  After 8 days the symptoms are now mild.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown age and gender. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates, the patient were vaccinated with improperly stored doses of PNEUMOVAX 23 (lot # M006139, expiration date 13-MAY-2017; lot # M005287, expiration date 08-OCT-2017, dose and route not reported). The doses of vaccine were improperly stored at 34 degree Fahrenheit for 228.5 hours. There were no previous excursions. No data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
08/18/2018 8:30am Pt's mother called stating that her son received the 2nd HPV the previous day and woke up with dizziness, nausea and vomiting. 8/18/18 9:24am Nurse, LVN called mother and spoke to her, mother denied patient having any SOB, swelling to lips, tongue, nose, hands or feet.  No itching to tongue or throat or difficulty swallowing. No swelling to hands or feet either. Nurse instructed patient to give BENADRYL every 4-6 hours and if that didn't help or if child didn't improve she should take him to his PCP. Mom agreed. 8/18/18 10:40am Mother contacted nurse again and stated the patient's left eye and hand were slightly swollen and itching but that the BENADRYL was helping (she gave BENADRYL at 945am). 08/19/2018 1059am Mother contacted Nurse again stating that she gave ZOFRAN and BENADRYL for the n/v/d that started last night, and gave him ZYRTEC today instead of the BENADRYL because it was too sedating. She also stated she tried to get him seen at clinic, but was refused because they did not administer the immunization.  She is in the process of getting into see his PCP. She denied any respiratory symptoms at this time.
The patient developed an itchy rash near the injection site about 4-5 inches in length and 2-3 inches in width. No other sympotoms noted at this time.
This is a spontaneous report from a contactable pharmacist via a sales representative. A male patient of an unspecified age received PREVNAR 13 (lot number and expiration date unknown) via an unspecified route of administration on an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. On an unspecified date, the reporter stated that a patient after receiving his pneumococcal 13-valent conjugated vaccine (diphtheria crm197 protein) injection there was severe swelling and redness at the injection site and the redness spread down the patients arm and the patient eventually was prescribed an antibiotic. The outcome for the events was unknown. No follow-up attempts are possible, information about batch number cannot be obtained.
I had fever chills, body aches, pain at injection site. Swelling at lymph nodes at axillary and clavicle. Never went away even before My 3rd dose.
Localized reaction to PENTACEL vaccination. 8x11cm erythematous area to right medial thigh slightly warm to touch, erythema fades as infant calms down.
left arm from fingers to elbow rash that itches and is raised in some areas. Now the rash is on my hand and forearm
Diarrhea; Fatigue; Thrown up, described as vomited; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concomitant products included AMLODIPINE, LOSARTAN and TEMAZEPAM for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea). On 12-Apr-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, FATIGUE (Fatigue), VOMITING (Thrown up, described as vomited) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   He called his primary care physician about three or four days ago and was told that he does not know anything about the vaccine and there was nothing which he could tell the patient about the vaccine. The patient asks whether it is common for the reported symptoms to be lasting this long and asks is it safe for him to get the second dose, scheduled for next Monday 19Apr2021, with these ongoing symptoms.The patient grants permission for Safety follow up and grants permission for Safety to follow up with his health care professional. Treatment details include, the patient has not treated his symptoms
7/27/12 patient went to Urgent Care c/o swelling about size of tennis ball, redness and warm to touch.
Arm hurting a bit; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurting a bit) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced PAIN IN EXTREMITY (Arm hurting a bit). At the time of the report, PAIN IN EXTREMITY (Arm hurting a bit) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient confirmed that he received both Moderna vaccines and not Pfizer. It was reported the patient received the second dose of the vaccine on 14-Jun-2021.  No Concomitant  information was  provided. No Treatment information was  provided.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up reiceved on 27-Jul-2021.  Significant Follow up received.  Event outcome updated to resolved.
Patient was administered expired dose at 17 hours and 10 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered expired dose at 17 hours and 10 minutes) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939901) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered expired dose at 17 hours and 10 minutes). On 26-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered expired dose at 17 hours and 10 minutes) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication were provided by reporter. No treatment medication were provided by reporter.
rheumatoid arthritis; stress response caused her to also develop shingles; This spontaneous case was reported by a consumer and describes the occurrence of RHEUMATOID ARTHRITIS (rheumatoid arthritis) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history. ).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RHEUMATOID ARTHRITIS (rheumatoid arthritis) (seriousness criterion medically significant) and HERPES ZOSTER (stress response caused her to also develop shingles). At the time of the report, RHEUMATOID ARTHRITIS (rheumatoid arthritis) and HERPES ZOSTER (stress response caused her to also develop shingles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information not provided  Very limited information regarding this event has been provided at this time.  No follow up is possible   This case was linked to MOD-2021-067542 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time.  No follow up is possible MOD-2021-067542:Valid case
Became lightheaded, SOB and vomiting. Told the pt. to lay down, applied ice to back of neck and cool compress to forehead. Got Dr. to check Pt.